Status:
UNKNOWN
The Use of PET for the Early Response Evaluation in Patients With Diffuse Large B-cell Lymphoma.
Lead Sponsor:
Odense University Hospital
Collaborating Sponsors:
University of Southern Denmark
Conditions:
Diffuse Large B-cell Lymphoma
Eligibility:
All Genders
18+ years
Brief Summary
Non-Hodgkin lymphoma (NHL) is one of the more frequent cancers in the western world with approx. 800 new cases annually in Denmark. Diffuse large B-cell lymphoma (DLBCL) in Denmark accounts for almost...
Eligibility Criteria
Inclusion
- Age\>18 years
Exclusion
- Previously treatment with chemotherapy or irradiation
- Primary CNS lymphoma
- Recurrent lymphoma
- Transformation from indolent lymphoma
- Presence of diabetes mellitus, HIV, chronic inflammatory disease or infections
- Planned for curative treatment
Key Trial Info
Start Date :
June 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2014
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01865058
Start Date
June 1 2011
End Date
August 1 2014
Last Update
May 30 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hematology Rearch Unit, Odense University Hospital
Odense, Fyn, Denmark, 500